A) True
B) False
Answer: B
Gadolinium may cause an adverse fetal outcome. Use GBCA only if ABSOLUTELY necessary. GBCA in utero is associated with increased rates of neonatal death. It may also be associated with rheumatologic or inflammatory skin conditions through age 4.
#pharmacology
#neurology
#radiology
#ob-gyn
References:
1. Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA 2016; 316:952.
2. Alghamdi SA Sr. Gadolinium-Based Contrast Agents in Pregnant Women: A Literature Review of MRI Safety. Cureus. 2023 May 3;15(5):e38493. doi: 10.7759/cureus.38493. PMID: 37273372; PMCID: PMC10237509.
3. Coyte RM, Darrah T, Olesik J, Barrett E, O'Connor TG, Brunner J, Love T, Perez-D'Gregorio R, Wang HZ, Aleksunes LM, Buckley B, Doherty C, Miller RK. Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy. Birth Defects Res. 2023 Aug 15;115(14):1264-1273. doi: 10.1002/bdr2.2209. Epub 2023 Jun 19. PMID: 37334869; PMCID: PMC11784526.